Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when COSM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCosmos Health reports record FY 2025: revenue up 20% to $65.3M, gross profit surges 83%
Filed April 16, 2026 · Period ending April 15, 2026 · ~1 min read
Key Changes
-
high
Revenue hit all-time high of $65.3 million, up 20% year-over-year, driven by growth across core business segments.
Item 2.02 verify on EDGAR → -
high
Gross profit jumped 83% to $7.9 million with margins expanding 418 basis points, indicating improved pricing power and cost management.
Exhibit 99.1 view on EDGAR → -
high
Adjusted earnings per share improved 82%, reflecting strong operating leverage and profitability gains flowing to shareholders.
Exhibit 99.1 view on EDGAR → -
medium
Cash position increased tenfold to $3.5 million, significantly strengthening balance sheet liquidity for operations and growth.
Exhibit 99.1 view on EDGAR → -
medium
Management reports record growth continuing into 2026 across all core segments, suggesting sustained business momentum.
Exhibit 99.1 view on EDGAR →
Summary
Cosmos Health delivered a breakout fiscal 2025, posting record revenue of $65.3 million (up 20%) while dramatically improving profitability metrics. The standout performance was an 83% surge in gross profit to $7.9 million, with margins expanding over 400 basis points—a sign the company is either commanding better pricing, managing costs more effectively, or shifting to higher-margin products.
Adjusted EPS improved 82%, and cash on hand grew from roughly to $3.5 million, giving the small-cap healthcare company meaningful financial breathing room. For retail investors, this represents a significant operational inflection point. The combination of top-line growth and margin expansion suggests the business model is scaling efficiently.
Management's statement that growth is continuing into 2026 across all segments provides near-term visibility, though specifics on segment performance and sustainability remain to be seen in the full earnings materials. Watch for the detailed earnings call transcript or investor presentation to understand which segments drove the margin gains and whether the cash buildup signals reduced capital needs or preparation for strategic investments. The 10-K filing due within 90 days will provide full financial statements and risk factor updates.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Cosmos Health announced fiscal year 2025 financial results via press release; full details in attached Exhibit 99.1.
Added in current filing · verify on EDGAR →
On April 15, 2026, Cosmos Health Inc. (the “Company”) issued a press release setting forth its financial results for the fiscal year ended December 31, 2026.
The company disclosed its full-year 2025 financial results through a press release on April 15, 2026. The actual financial metrics and performance details are contained in the attached press release (Exhibit 99.1), which is not included in this 8-K body. This is a standard earnings announcement filing where the substantive information resides in the exhibit.
Event · Item 9.01 — Financial Statements and Exhibits
Cosmos Health disclosed full year 2025 results: revenue $65.3M (up 20%), gross profit $7.9M (up 83%), adjusted EPS improved 82%, cash $3.5M (up 10x).
Added in current filing · verify on EDGAR →
Adjusted EPS Improves 82%
Adjusted earnings per share improved by 82% year-over-year. This significant bottom-line improvement reflects the company's operating leverage and profitability gains translating to shareholder value.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify